Although Sema3A inhibits endothelial formation and angiogenesis due to competition with VEGF165 [51], this study did not identify a significant correlation between Sema3A mRNA expression levels and blood vessel density in RA synovial tissues. This evidence concerns the gene SEMA3A and rheumatoid arthritis.